Cutaneous macroglobulinosis treated with bortezomib and rituximab

Eur J Haematol. 2011 Jul;87(1):98. doi: 10.1111/j.1600-0609.2011.01610.x. Epub 2011 May 25.

Authors

Tony Marchand¹, Patrick Tas, Roch Houot, Charles Dauriac, Thierry Lamy, Xavier Cahu

Affiliation

¹ Department of Hematology, CHU Rennes, Hôpital Pontchaillou, Rennes, France.

PMID: 21418108
DOI: 10.1111/j.1600-0609.2011.01610.x

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal, Murine-Derived / administration & dosage*
Boronic Acids / administration & dosage*
Bortezomib
Humans
Immunoglobulin M / metabolism
Male
Pyrazines / administration & dosage*
Recurrence
Rituximab
Skin Diseases / immunology
Skin Diseases / pathology
Skin Diseases / therapy*
Waldenstrom Macroglobulinemia / immunology
Waldenstrom Macroglobulinemia / pathology
Waldenstrom Macroglobulinemia / therapy*

Substances

Antibodies, Monoclonal, Murine-Derived
Boronic Acids
Immunoglobulin M
Pyrazines
Rituximab
Bortezomib